-
Use of Latent Class Analysis to Identify Patient Symptom Burden Subgroups after Living Donor Kidney Transplant
-
Use of Low Dose Interleukin-2 to Expand Regulatory T-cells and Facilitate the Complete Discontinuation of Immunosuppression in Human Liver Transplantation
-
Use of Marginal Liver Donors in Pediatric Transplantation: Diverse Profiles of Use in Major Transplant Centers
-
Use of mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Breaking False Myths
-
Use of Opioids and NSAIDs in Living Kidney Donors: Clinical Correlates and Early Outcomes
-
Use Of Perirenal Adipose Tissue As A Source Of Donor Cells Allowing Evaluation Of Endothelial Inflammation And Quality Of Expanded Criteria Kidneys
-
Use of TruGraf Serial Testing for Confirming Stability in Kidney Transplant Patients with Stable Renal Function
-
Use, Safety and Effectiveness of Hepatitis B Virus NAT-Positive Donor Livers in the Current Era
-
Usefulness of the Assessment of CT-Based Donor Kidney Function Compared with Radionuclide Scintigraphy
-
Using a Commercially Available Assay That Measures Cytomegalovirus-Specific CD4+ and CD8+ T-cell Immunity to Predict Clinically Significant Cytomegalovirus Events in Solid Organ Transplant Recipients
- « Previous Page
- 1
- …
- 205
- 206
- 207
- 208
- 209
- …
- 214
- Next Page »